Article metrics
PDF
Other content recommended for you
- Risk factors for detecting germline BRCA1 and BRCA2 founder mutations in Ashkenazi Jewish women with breast or ovarian cancer
- Breast and ovarian cancer risks in a large series of clinically ascertained families with a high proportion of BRCA1 and BRCA2 Dutch founder mutations
- Cohort profile: the MCC-Spain follow-up on colorectal, breast and prostate cancers: study design and initial results
- BRCA1, BRCA2 and CHEK2 c.1100 delC mutations in patients with double primaries of the breasts and/or ovaries
- A Finnish founder mutation in RAD51D: analysis in breast, ovarian, prostate, and colorectal cancer
- High frequency of BRCA1/2 germline mutations in 42 Belgian families with a small number of symptomatic subjects
- Coverage of common cancer types in UK national newspapers: a content analysis
- Cancer risks in first degree relatives of BRCA1 mutation carriers: effects of mutation and proband disease status
- Nordic collaborative study of the BARD1 Cys557Ser allele in 3956 patients with cancer: enrichment in familial BRCA1/BRCA2 mutation-negative breast cancer but not in other malignancies
- Genes other than BRCA1 and BRCA2 involved in breast cancer susceptibility